Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway: early value assessment

Committee members

This topic was considered by NICE's diagnostics advisory committee, which is a standing advisory committee of NICE.

Committee members are asked to declare any interests in the technologies to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of the diagnostics advisory committee meetings, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Additional specialist committee members took part in the discussions and provided expert advice for this topic:

Specialist committee members

Eugene Healy
Department chair & head of dermatology, University of Southampton, and honorary consultant dermatologist, University Hospital Southampton NHS Foundation Trust

Kate Hawley
Lay member

Nalayini Kumaralingam
Nurse consultant, Kent Oncology Centre, Maidstone Hospital

Roger Aldridge
Consultant plastic surgeon & consultant dermatological surgeon, NHS Lanarkshire & NHS Lothian

Rubeta Matin
Consultant dermatologist, Oxford University Hospitals NHS Foundation Trust

Stephanie Gallard
Dermatology GP with special interest (GPSI), Liverpool Intermediate Community Assessment and Treatment Service (ICATS) & Liverpool University Foundation Trust

Stephen McKenna
Professor, research cluster lead (computer sciences & informatics), University of Dundee

Susan Mountain
Lay member

NICE project team

Each early value assessment topic is assigned to a team consisting of 1 or more health technology assessment analysts (who act as technical leads for the topic), a health technology assessment adviser and a project manager.

Anam Khan
Health technology assessment analyst

Frances Nixon
Health technology assessment adviser

Toni Gasse
Project manager

ISBN: